Downregulated DEGs |
GO Terms of Biological Processes (BPs) |
GO:0060337~type I interferon signaling pathway [46] |
12 |
8.41E-13 |
OAS1, OAS3, IRF9
|
GO:0051607~defense response to virus [47] |
12 |
2.72E-08 |
OAS1, OAS3, IRF9
|
GO:0060333~interferon-gamma-mediated signaling pathway [47] |
6 |
1.53E-04 |
OAS1,OAS3, IRF9, ATF6B
|
GO:0045071~negative regulation of viral genome replication [48] |
5 |
1.86E-04 |
OAS1, OAS3
|
GO:0055114~oxidation-reduction process [49] |
9 |
0.06191 |
NQO1, HPGD, AKR1C1
|
GO Terms of Cellular Components (CCs) |
GO:0005737~cytoplasm [50] |
57 |
4.91E-05 |
OAS1, OAS3, IRF9, HPGD, TP53INP1, NQO1
|
GO:0005578~proteinaceous extracellular matrix [8] |
7 |
0.009721 |
FN1
|
GO Terms of Molecular Function (MF) |
GO:0016491~oxidoreductase activity [51] |
5 |
0.032918 |
HPGD, AKR1C1
|
Upregulated DEGs |
GO Terms of BP |
GO:0045944~positive regulation of transcription from RNA polymerase II promoter [52] |
7 |
0.014821 |
BCL11A, SLCO2A1
|
GO:0000122~negative regulation of transcription from RNA polymerase II promoter [53] |
6 |
0.015973 |
BCL11A, NT5E
|
GO Terms of CC |
GO:0072559~NLRP3 inflammasome complex [54] |
2 |
0.017428 |
FN1
|
GO Terms of MF |
GO:0097153~cysteine-type endopeptidase activity involved in apoptotic process [55] |
2 |
0.02663 |
FN1
|
KEGG pathways |
DEGs (Counts) |
P-Value |
Associated KGs |
Downregulated DEGs |
hsa05168:Herpes simplex infection [56] |
6 |
0.012895 |
OAS1, OAS3, ATF6B, IRF9
|
Upregulated DEGs |
hsa04151:PI3K-Akt signaling pathway [57] |
4 |
0.030138 |
ANGPT1, SLCO2A1, BCL11A
|